Recent

% | $
Quotes you view appear here for quick access.

Santarus, AŞ Message Board

  • minnesotafarmcountry minnesotafarmcountry Aug 22, 2013 7:49 PM Flag

    Seriously ... a "survey"?

    He attributed that mostly to the strong launch of bowel-disease drug Uceris earlier this year, but wrote that a recent survey of gastroenterologists suggested to him that sales will not exceed current consensus.

    You're kidding, right? A recent survey ... how many people, Jason? And, the reason it outperformed is because they consistently beat estimates. But, now we're supposed to believe some "anal"yst that cites a survey! What's next, my brother's girlfriend's sister's cousin says ...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Whats even more ridiculous is that according to the companies he follows and recommends, as of July 28 he still had Santarus as outperform. Santarus kills earnings, two weeks later he comes out with a lame downgrade at market perform to 26 bucks. I never found anything with price targets but where in the world after only two weeks would would you even think of going from 28 to 26 after impressive earnings. If anything you'd think he would say market perform but keep 28 price target. As for competing with Shire, its total speculation on his part. He also has Shire as Outperform by the way. His earnings number as of July 28 2013 was way off base by the way. Its like he didn't even listen or read 1st quarter numbers. Santarus since earnings sure has been hit with shorts and I wonder if his little story helped his buddies out. I would really like to see some of Santarus big investors come out with reiterations or upgrades to the company soon.

      Sentiment: Strong Buy

    • it's sick..I wouldn't mind if it was a "real" survey.....total scam

 
SNTS
0.00(0.00%)